SHP2-associated Noonan Syndrome and cardiomyopathies have symptoms that resemble those in primary mitochondrial disorders75, and disease-associated activating SHP2 mutants have been shown to impact mitochondrial function and homeostasis71,76. Here, PTPN11 is linked to cardiomyopathy.